FIELD: medicine, ophthalmology.
SUBSTANCE: the present innovation deals with treating retinitis pigmentosa with the help of enzymes and applying a pharmaceutical composition as a kit applied for such therapy. The kit suggested contains the following enzymes: glutathione peroxidase, prolidase, glucose-6-phosphate dehydrogenase and, non obligatory, aldose reductase in aliquot portions and interactive quantities being acceptable to introduce the enzymes mentioned in accordance with the preset temporal sequence. The innovation enables to create the method for treating retinitis pigmentosa which provides the chance for gradual reconstruction of acuity, distinct picture and perception of colors.
EFFECT: higher efficiency of therapy.
13 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
| METHOD FOR TREATMENT OF DIABETIC RETINOPATHY WITH PREPARATION "BOL-KHIT" | 2006 |
|
RU2301675C1 |
| METHOD OF TREATING ACUTE THROMBOSIS OF RETINA VEINS | 2010 |
|
RU2416402C1 |
| TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
| METHOD FOR INTEGRATED PATHOGENETIC TREATMENT OF CENTRAL AND PERIPHERAL TAPETORETINAL DYSTROPHIES WITH APPLYING CELL TECHNOLOGIES | 2011 |
|
RU2467730C2 |
| METHOD OF TREATING OPTIC NERVE ATROPHY IN INFANTS | 2011 |
|
RU2458702C1 |
| TREATMENT OF RETINITIS PIGMENTOSA WITH N-ACETYLCYSTEINE AMIDE | 2015 |
|
RU2711913C2 |
| METHOD OF SUBRETINAL TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, WITH ATROPHY OF RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2019 |
|
RU2729937C1 |
| METHOD FOR THROMBOLYSIS IN CIRCULATORY DISORDERS OF THE EYEBALL AND THE RETROBULBAR SPACE (VARIANTS) | 2021 |
|
RU2785494C1 |
| DEMETHYLATION FOR TREATMENT OF EYE DISEASE | 2019 |
|
RU2804300C2 |
